Most AI medical coding tools on the market today are, at their core, wrappers. They take a general-purpose large language model—the kind trained on Reddit threads, Wikipedia articles, and recipe blogs—and layer a prompt on top of it that says, roughly, “pretend you’re a medical coder.” The result is a tool that can sound authoritative about CPT codes while quietly getting clinical nuances wrong.
Ensemble Health Partners and Cohere saw this gap and decided to do something structurally different. On March 31, 2026, the two companies announced a partnership to build the healthcare industry’s first revenue cycle management (RCM)-native large language model—a purpose-built model trained on revenue cycle data from the ground up, not adapted after the fact from a general-purpose corpus.
That distinction matters more than most coders realize, and the implications extend well beyond Ensemble’s own clients.
What Makes Medical Coding Different From Other Language Tasks
Medical coding is not a reading comprehension problem. It is a multi-step reasoning task that requires simultaneously understanding clinical context, payer-specific policy, procedure sequencing rules, modifier logic, and the interaction between diagnosis and procedure codes—all derived from unstructured narrative documentation.
General LLMs are trained on the full breadth of human text. That makes them fluent. It does not make them reliable where reliability is measured in reimbursement dollars and audit exposure.
The RCM Vocabulary and Logic Problem
RCM has its own operational logic layer—one that maps clinical language onto payer-specific payment rules. A physician note might describe “bilateral total knee arthroplasty, performed in stages.” A coder needs to know that staged procedures require modifier -58, that bilateral coding depends on whether the payer accepts a bilateral-specific CPT code or modifier -50, and that the MS-DRG assignment turns on how principal versus secondary diagnoses are sequenced. General LLMs have read plenty of coding forums. They have not been trained on the specific decision patterns—denial reasons, CDI query outcomes, payer clinical policies—that govern real RCM workflows.
What Ensemble and Cohere Are Actually Building
Ensemble Health Partners manages end-to-end revenue cycle operations for more than 30 health systems across the United States. That operational scale means Ensemble sits on a deep dataset of RCM decisions: prior authorization outcomes, denial patterns, coding corrections, CDI query responses, and claim edit resolution logic. This is exactly the structured operational knowledge that general LLMs are missing.
The March 31, 2026 partnership with Cohere aims to convert that expertise into a custom model. Unlike recent market offerings that wrap prompts around general-purpose LLMs, Ensemble and Cohere are building a fully custom model fine-tuned on synthetic RCM datasets—zero patient health information, fully HIPAA-compliant—shaped by Ensemble’s coding and denial management workflows. The result is intended to be an LLM capable of real orchestration: linking patient intake, coding, prior authorization, and claim resolution as a connected workflow rather than a series of disconnected steps.
The model is expected in the second half of 2026. Ensemble plans to embed it into AI agents that span the revenue cycle end-to-end, from registration to final account resolution.
Why Domain-Specific Training Matters for Accuracy and Compliance
The accuracy gap between general and domain-specific models is not theoretical. When Corti launched Symphony for Medical Coding in April 2026—another purpose-built agentic model trained specifically on medical coding tasks—it outperformed general LLMs from OpenAI, Anthropic, Amazon, Oracle, and Google by more than 25% in clinical accuracy benchmarks. That margin represents real dollars: miscoded claims, missed diagnoses, and documentation gaps that convert directly into denials, downcoding, and audit exposure.
Compliance is the other dimension. When a purpose-built RCM model generates a coding recommendation, it can cite the specific documentation evidence or coding guideline driving that recommendation. General LLMs cannot do this reliably—they produce confident-sounding output without traceable rationale. In an environment where coding decisions need to survive a payer audit or OIG review, explainability is not a nice-to-have.
What Coding Teams Should Watch For
As RCM-native LLMs enter the market in the second half of 2026 and beyond, several things will shift for coding and CDI teams:
- Coding rationale will become traceable. Purpose-built models link coding recommendations to specific documentation evidence, making audit trails cleaner and compliance review faster than today’s black-box suggestions.
- Denial prevention will move upstream. A model that understands payer-specific clinical policies can flag a likely denial before a claim is submitted—not after it is rejected and sitting in the denial queue.
- CDI query logic will sharpen. RCM-native models understand the relationship between documentation specificity and MS-DRG assignment in ways general LLMs do not, enabling more targeted queries that actually move the revenue needle.
- Vendor evaluation criteria will evolve. “We use AI” will matter less than “what was your model trained on” and “how do you measure accuracy against our payer mix and specialty mix.”
The Question to Ask Every Vendor
The emergence of purpose-built RCM models creates a new due-diligence question for any coding or revenue cycle team evaluating AI tools: Is this model trained on revenue cycle data, or is it a general-purpose model with an RCM-flavored prompt in front of it?
That question will not always get a straight answer. Vendors have commercial incentives to obscure the distinction, and marketing language around “AI trained on clinical data” can mean many things. But the clinical accuracy benchmarks, the explainability of coding rationale, and the model’s ability to handle payer-specific clinical policy variations will reveal the answer quickly in any pilot evaluation.
The Ensemble-Cohere partnership is the clearest industry signal yet that the market is moving toward specialized, operationally-trained models. General-purpose LLMs helped demonstrate that AI could assist with medical coding. RCM-native models are being built to prove it can get the details consistently right—at scale, across payer mixes, under audit scrutiny.
For health systems and coding teams building their AI vendor strategy now, understanding this distinction is worth the time before the H2 2026 product launches arrive and the competing marketing claims make it harder to see the underlying architecture.
If you’re evaluating AI for coding, CDI, or revenue integrity, Medikode’s automated medical coding platform is built on specialized clinical reasoning—designed to deliver traceable, auditable coding recommendations from day one.